ATN 025 Review of Symptoms Form, Version 2: Other Body System [CRF 6] Dataset in Hepatitis B Vaccination in Youth at Adolescent Trials Network Sites: Effectiveness of Two Strategies and Evaluation of Tools to be Used in Future HIV Prevention Trials

Data from Review of Symptoms Form, Version 2: Other Body System [CRF 6]
Study Description
A randomized, single-blinded trial evaluating two licensed vaccine products, Recombivax and Twinrix, given in a two-dose schedule to youth at risk for HIV and hepatitis B infection. Primary objectives were to determine immunogenicity of the products in the study population and to determine safety and tolerability of the vaccines given in the two regimens.
HIV and hepatitis B negative youth aged 12 to 17

症状调查问卷（第2版：其他身体系统）数据 [病例报告表6（CRF 6）]
研究概况
本研究为一项随机单盲试验，旨在评估两款已获批上市的疫苗产品——重组乙型肝炎疫苗（Recombivax）与甲乙型肝炎联合疫苗（Twinrix）——以两剂次接种方案应用于HIV及乙型肝炎病毒感染高风险青少年的效果。首要研究目标为明确两款疫苗在本研究人群中的免疫原性，以及两种接种方案下疫苗的安全性与耐受性。
本研究的研究对象为12至17岁的HIV及乙型肝炎病毒检测阴性青少年。